Programmed cell death receptor 1 inhibitors combined with paclitaxel-platinum induction chemotherapy for treating patients with locally advanced nasopharyngeal carcinoma: a real-world retrospective study
{{output}}
Background: Concurrent chemoradiotherapy (CCRT) combined with induction chemotherapy (IC) is the standard first-line treatment for locally advanced nasopharyngeal carcinoma (LA-NPC). However, treatment-related toxicities and the ... ...
